Phase 3 Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are female
- People who are over 18 years old
- People who have been diagnosed with breast cancer
- People whose treatment plan includes chemotherapy, with a planned total dose equivalent to 240 mg/m2 of doxorubicin (a specific chemotherapy drug)
Who may not be able to join:
- People who have a pacemaker, cardiac defibrillator, metal clips used for a brain aneurysm, cochlear implant (hearing implant), or a valve that drains fluid from the brain to the abdomen, as these can interfere with the type of scan used in this trial
- People who are unable to undergo the required type of scan (a cardiac MRI) due to severe claustrophobia (fear of enclosed spaces)
- People who have significant kidney problems, specifically a low kidney filtration rate below a certain threshold (confirm with trial site for exact details)
- People who have a previous history of heart attack, heart failure, or procedures to restore blood flow to the heart (whether by surgery or a less invasive procedure)
- People who have a previous history of significant heart valve disease
- People who have a previous history of diseases affecting the heart muscle (cardiomyopathies)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Otavio Rizzi Coelho-Filho, MD, MPH, PhD, University of Campinas, Brazil
Phone: +55 19 3521-7755
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in left ventricle ejection fraction
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.